Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

202 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical significance of BRAF mutations in metastatic melanoma.
Chang DZ, Panageas KS, Osman I, Polsky D, Busam K, Chapman PB. Chang DZ, et al. Among authors: chapman pb. J Transl Med. 2004 Dec 21;2(1):46. doi: 10.1186/1479-5876-2-46. J Transl Med. 2004. PMID: 15613230 Free PMC article.
Medical treatment of metastatic melanoma.
Houghton AN, Meyers ML, Chapman PB. Houghton AN, et al. Among authors: chapman pb. Surg Clin North Am. 1996 Dec;76(6):1343-54. doi: 10.1016/s0039-6109(05)70519-3. Surg Clin North Am. 1996. PMID: 8977555 Review.
Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide.
Lewis JJ, Janetzki S, Schaed S, Panageas KS, Wang S, Williams L, Meyers M, Butterworth L, Livingston PO, Chapman PB, Houghton AN. Lewis JJ, et al. Among authors: chapman pb. Int J Cancer. 2000 Aug 1;87(3):391-8. doi: 10.1002/1097-0215(20000801)87:3<391::aid-ijc13>3.0.co;2-k. Int J Cancer. 2000. PMID: 10897045 Free article. Clinical Trial.
T-cell responses against tyrosinase 368-376(370D) peptide in HLA*A0201+ melanoma patients: randomized trial comparing incomplete Freund's adjuvant, granulocyte macrophage colony-stimulating factor, and QS-21 as immunological adjuvants.
Schaed SG, Klimek VM, Panageas KS, Musselli CM, Butterworth L, Hwu WJ, Livingston PO, Williams L, Lewis JJ, Houghton AN, Chapman PB. Schaed SG, et al. Among authors: chapman pb. Clin Cancer Res. 2002 May;8(5):967-72. Clin Cancer Res. 2002. PMID: 12006508 Clinical Trial.
202 results